Pharmaceutical Services Negotiating Committee

Senderra Specialty Pharmacy Expands Production Capabilities Opening a New State-of-The-Art Distribution Facility

Retrieved on: 
Friday, September 29, 2023
Pharmaceutical Services Negotiating Committee, Artificial intelligence, Growth, Entrepreneurship, Health, Patient, Movement, Hospital, Nursing, DALLAS

DALLAS, Sept. 29, 2023 /PRNewswire/ -- Senderra Specialty Pharmacy, a leading national provider of specialty pharmacy services, is thrilled to announce the opening of its new location in Plano, Texas. This state-of-the-art facility is designed to meet the growing demand for specialized pharmaceutical services for our valued patients. The new facility spans over 30,000 square feet of innovative infrastructure and has advanced features to ensure efficient operations.

Key Points: 
  • DALLAS, Sept. 29, 2023 /PRNewswire/ -- Senderra Specialty Pharmacy, a leading national provider of specialty pharmacy services, is thrilled to announce the opening of its new location in Plano, Texas.
  • This state-of-the-art facility is designed to meet the growing demand for specialized pharmaceutical services for our valued patients.
  • The new facility spans over 30,000 square feet of innovative infrastructure and has advanced features to ensure efficient operations.
  • The facility showcases two dedicated production lines with a combined length of 250 feet, enabling Senderra to streamline the fulfillment process and enhance our capacity to serve more patients.

Magellan Rx Pharmacy LLC earns URAC Reaccreditation in Specialty Pharmacy

Retrieved on: 
Monday, August 28, 2023
Pharmaceutical Services Negotiating Committee, Accreditation, Education, Pharmacy, MRX, Risk management, International Cataloguing Standards Committee, Hospital, Specialty pharmacy, Patient, Physician, Patient safety, URAC, Therapy, Conditional sentence, Nursing, Health care

EAGAN, Minn., Aug. 28, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce that Magellan Rx Pharmacy, LLC (Magellan Rx), MRx's specialty pharmacy, has earned URAC reaccreditation for Specialty Pharmacy.

Key Points: 
  • EAGAN, Minn., Aug. 28, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce that Magellan Rx Pharmacy, LLC (Magellan Rx), MRx's specialty pharmacy, has earned URAC reaccreditation for Specialty Pharmacy.
  • URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management.
  • By achieving this status, MRx demonstrates commitment to quality care, enhanced processes, patient safety and improved outcomes.
  • Given the complicated nature of chronic disease, pharmacies like Magellan Rx Pharmacy do much more than simply fill a prescription.

Scripx Joins Hands with MedAvail in Buying MedCenter, Remote Medication Disposal Units, to Revolutionize Patient Access to Medication Across Texas

Retrieved on: 
Wednesday, August 23, 2023
Pharmaceutical Services Negotiating Committee, Partnership, Pharmacy, LTC, Long-term care, University, Medicine, Prescription, Privacy, PCI, Hospital, Patient, Patient safety, Adherence (medicine), Health, HIPAA, Safety, Nursing

By leveraging MedCenter, Scripx Pharmacy aims to revolutionize medication access and reduce wait times for patients, marking a new era in pharmaceutical services.

Key Points: 
  • By leveraging MedCenter, Scripx Pharmacy aims to revolutionize medication access and reduce wait times for patients, marking a new era in pharmaceutical services.
  • The tailored formulary supports a wide range of medications, meeting specific clinical needs, while strict adherence to remote dispensing regulations prioritizes patient safety.
  • This partnership between two incredibly innovative organizations such as MedAvail and Scripx promises the delivery of exceptional pharmacy services to a wider patient community.
  • This seamless and efficient pharmacy experience is certain to set a new standard in patient care and convenience in the coming days.

Clinigen divests global rights to four cancer support therapies to CNX Therapeutics

Retrieved on: 
Thursday, August 10, 2023
Pharmaceutical Services Negotiating Committee, Heart, Laboratory, Radiation, Cancer, Greenhill & Co., Woman, Head, Cisplatin, Sale, Iovance Biotherapeutics, CNX, Patient, Drug Safety, Doxorubicin, Cardiomyopathy, Anthracycline, Therapy, Pharmaceutical industry, Fine chemical

Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the divestment of four cancer supportive care products from its established brands portfolio to CNX Therapeutics, a speciality pharmaceutical company with a focus on improving access to medicines that are critical to the well-being of patients.

Key Points: 
  • Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the divestment of four cancer supportive care products from its established brands portfolio to CNX Therapeutics, a speciality pharmaceutical company with a focus on improving access to medicines that are critical to the well-being of patients.
  • Cardioxane®, used in adults with advanced or metastatic breast cancer to prevent long-term harmful effects on the heart caused by treatment with certain anthracyclines.
  • Savene®, used to treat anthracycline extravasation in adults, a rare condition that can impact cancer patients.
  • Totect®, used for the treatment of anthracycline extravasation as well as for preventing cardiomyopathy associated with doxorubicin in women with metastatic breast cancer.

Scott B. Holden, MBA, CMA Joins COPILOT as Chief Financial Officer

Retrieved on: 
Monday, April 24, 2023
Pharmaceutical Services Negotiating Committee, Platform as a service, Certified Management Accountant, HUB, CMA, Health equity, ICON, Cancer, Holden, MBA, Bucknell University, Scott, Fairleigh Dickinson University, Patient, PWC, JD, Growth, Johnson & Johnson, Treasurer, Pharmaceutical industry, Management

MAITLAND, Fla., April 24, 2023 /PRNewswire/ -- COPILOT Provider Support Services LLC ("COPILOT"), a leading HUB specialty patient support services portfolio company of QHP Capital, LP—a life science focused private equity firm, announced that Scott B. Holden will join company as its Chief Financial Officer.  

Key Points: 
  • MAITLAND, Fla., April 24, 2023 /PRNewswire/ -- COPILOT Provider Support Services LLC ("COPILOT"), a leading HUB specialty patient support services portfolio company of QHP Capital, LP—a life science focused private equity firm, announced that Scott B. Holden will join company as its Chief Financial Officer.
  • COPILOT, a leading HUB specialty patient support services portfolio company of QHP Capital, announced that Scott B. Holden will join company as its Chief Financial Officer.
  • Charles A. Stevens, JD, MBA, COPILOT's Chief Executive Officer said, "Scott embodies COPILOT's values of supporting access to therapy and health equity.
  • Scott added, "I am excited to join COPILOT and provide value as we accelerate our growth and diversification strategies into multiple therapeutic areas.

Marlon Davis Joins COPILOT as VP of Business Development

Retrieved on: 
Monday, March 20, 2023
Pharmaceutical Services Negotiating Committee, Business development, HUB, Sunovion, AmerisourceBergen, Patient, Iroko, Growth, SVP, Pharmaceutical industry

MAITLAND, Fla., March 20, 2023 /PRNewswire/ -- COPILOT Provider Support Services LLC ("COPILOT"), a leading HUB specialty patient support services portfolio company of QHP Capital, LP—a life science focused private equity firm, announced today that Marlon Davis will join company as Vice President of Business Development.  

Key Points: 
  • HUB national business development and sales expert, tapped to join pharmaceutical services and patient support company in next stage of accelerated growth.
  • MAITLAND, Fla., March 20, 2023 /PRNewswire/ -- COPILOT Provider Support Services LLC ("COPILOT"), a leading HUB specialty patient support services portfolio company of QHP Capital, LP—a life science focused private equity firm, announced today that Marlon Davis will join company as Vice President of Business Development.
  • Marlon joins COPILOT from AmerisourceBergen's LASH Group and Biopharma Services.
  • Marlon joins COPILOT from AmerisourceBergen's LASH Group and Biopharma Services and is a seasoned business development executive with patient services, pharmaceutical services including specialty pharmacy, and national sales experience at several pharmaceutical manufacturers.

AutoCruitment Adds to Executive Team; Opens New Raleigh, North Carolina, Office

Retrieved on: 
Tuesday, March 14, 2023
Professional Services, Health, Human Resources, Clinical Trials, Research, Science, Corporation, CFO, University, MBA, Software as a service, Chapel Hill, Entrepreneurship, Finastra, World Wide Technology, IBM, Labcorp, State university system, General counsel, Syneos Health, ChannelAdvisor, University of North Carolina at Pembroke, Patient, Duke University, Bachelor of Arts in Clinical Psychology, Pharmaceutical Services Negotiating Committee, State University of New York at Oswego, Growth, Oswego, Ecosystem, K&L Gates, Management, IQVIA

Additionally, the Company announced the new North Carolina office location where both executives will be based.

Key Points: 
  • Additionally, the Company announced the new North Carolina office location where both executives will be based.
  • Twiddy joins AutoCruitment from ChannelAdvisor where she served as General Counsel of the global e-commerce SaaS company, which went private in November 2022.
  • She received a Bachelor of Arts and a Juris Doctor with honors from the University of North Carolina at Chapel Hill.
  • Additionally, the Company announced the opening of an office in Raleigh that will support the executive leadership team as well as future expansion and growth.

Orsini Earns Rare Disease Pharmacy Center of Excellence Designation from URAC

Retrieved on: 
Thursday, February 16, 2023
Fall Prevention Center of Excellence, Health, Pharmacy, URAC, Patient safety, ELK, Accreditation, Patient, Certification, Pharmaceutical Services Negotiating Committee, Disease, Education, Quality of life, Rare, Hospital, Nursing

ELK GROVE VILLAGE, Ill., Feb. 16, 2023 /PRNewswire/ -- Orsini Specialty Pharmacy today announced that the company earned URAC's prestigious designation as a Rare Disease Pharmacy Center of Excellence.

Key Points: 
  • ELK GROVE VILLAGE, Ill., Feb. 16, 2023 /PRNewswire/ -- Orsini Specialty Pharmacy today announced that the company earned URAC's prestigious designation as a Rare Disease Pharmacy Center of Excellence.
  • Their Center of Excellence designation recognizes specialty pharmacies that demonstrate a commitment to quality health services, patient safety, and improved outcomes for patients living with rare diseases.
  • "By achieving URAC accreditation, Orsini demonstrates excellence in quality care delivery and their long-term commitment to ensuring patient safety and improving outcomes."
  • URAC awarded Orsini the Rare Disease Pharmacy Center of Excellence for meeting or exceeding rigorous program standards for patient management, staff education, coordinated patient care, and care transitions.

American Oncology Network’s In-House Specialty Pharmacy Re-Accredited by URAC

Retrieved on: 
Monday, January 30, 2023
Education, Pharmacist, Insurance, Pharmaceutical Services Negotiating Committee, Pharmacy, Accreditation, Physician, CSP, Conditional sentence, Patient, URAC, Prescription, M.D, AON, Doctor of Pharmacy, Hospital

FORT MYERS, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) -- The American Oncology Network, LLC (AON) in-house specialty pharmacy received re-accreditation with zero deficiencies through URAC.

Key Points: 
  • FORT MYERS, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) -- The American Oncology Network, LLC (AON) in-house specialty pharmacy received re-accreditation with zero deficiencies through URAC.
  • “We applaud the AON specialty pharmacy for once again achieving URAC accreditation.
  • Given the complicated nature of chronic disease, pharmacies like the AON specialty pharmacy do much more than simply fill a prescription.
  • For more information about URAC specialty pharmacy accreditation, visit https://www.urac.org/accreditation-cert/specialty-pharmacy/ .

American Oncology Network Unites With Oncology Care Partners to Bring Patient Experience Focus to Cancer Care in Phoenix

Retrieved on: 
Thursday, January 19, 2023
MPH, MSA, Pharmaceutical Services Negotiating Committee, AON, Pharmacy, Quality of life, OCP, Health, Medicare, Patient, Cancer, Physician, Medicine, Phoenix, MD

By building collaborative partnerships with other providers and health plans, AON and OCP are accelerating the adoption of value-based care, improving the journey to better health and quality of life while reducing unnecessary services and lowering costs.

Key Points: 
  • By building collaborative partnerships with other providers and health plans, AON and OCP are accelerating the adoption of value-based care, improving the journey to better health and quality of life while reducing unnecessary services and lowering costs.
  • “I’m thrilled to be working with Oncology Care Partners to provide the very best treatment and experience in a comfortable, simplified journey for patients in the Phoenix community,” said Dr. Kahn.
  • “With cancer costs rising exponentially, we see an opportunity to create a better patient journey in medical oncology care that also provides value for at-risk physicians and payers,” said Erich Mounce, OCP Chief Executive Officer.
  • By clinically integrating with AON, practices leverage AON as a resource to make better evidence-based clinical decisions and improve patient outcomes while maintaining independence.